40 years of experience in the biomedical industry.

Served as President for Medical Division of Gould and British Oxygen in Tokyo and took the company to IPO through leverage buyout in Nasdaq.

Founder & CEO of Biosensors International Group (柏盛国际). Parent company of JWMS.

Member of National Research Foundation since 2016.

Lecturer at both Stanford University Biodesign in USA and invited speaker to NUS & NTU.

Limited & Venture Partner of Vertex Healthcare Singapore.

Team leader at Biosensors (柏盛国际) for technology transfer including Biolimus drug and device from USA to Singapore.

20 years of experience in the biomedical and pharmaceutical industry as a technical leader with successful track record of take products from R&D to commercial.

Inventor / co-inventor of multiple worldwide patents.

Professional manager with decades of diverse business development experience across Asia in medtech, medical aesthetic, food manufacturing and franchise operations.

Experience in IPO process (Biosensors 柏盛国际) , startups fundraising and operations.

Co-Founder, President and CEO of Bonti, which was acquired by Allergan (NASDAQ:AGN) in October 2018 for the upfront payment of $195 million and significant subsequent milestone payments;

Served at Allergan in various leadership roles, including Global Product Development teams of top tier neurotoxin, CMO management and ocular programs.

More than 20 years of experience in various leadership roles in the Biopharmaceutical industry.

Current Managing Partner of Evia Real Estate. Singapore based property developer with portfolio amounting to S$5.4billion. Its portfolio covers residential, commercial and industrial developments in Singapore and South Korea.

Served at multiple senior F&B positions in Malayan Breweries, Anchor and Tiger Beer.

MD of Pepsi Franchise Business for SEA countries.

President (Asia) for Masterfoods, food division of Mars Inc.

Independent Director of Biosensors International & Food Junction.

More than 30 years of operations, BD, franchise, property development and management experience.

Head and Senior Consultant Ophthalmologist of the Glaucoma Service at the Singapore National Eye Centre;

Director and Head of the Ocular Therapeutics and Drug Delivery Research Group at the Singapore Eye Research Institute; published over 200 scientific papers and delivered numerous presentations as invited speaker at international conferences, academic institutes and universities.

Ophthalmologist based in California

Highly experienced injector, clinical researcher & thought leader in medical facial aesthetic field.

Highly experienced PI in clinical trials including LATISSE for Allergan.

Current adviser to Allergan, Galderma and Merz.